Transient high titers of HIV-1 in plasma and progression of disease

Article Abstract:

Periods of high levels of HIV in blood may be associated with progression and symptoms of the disease. Researchers studied the presence of HIV in the blood of 28 HIV-positive people who had CD4 cell counts of 300 or less. Some patients experienced brief periods of high levels of HIV in their blood. These periods were associated with such symptoms as fever, rash, and infections associated with a weakened immune system. CD4 cell counts of 50 or less and declining CD4 cell counts were also associated with high blood levels of the virus. The syncytium-inducing strain of HIV was often found during these periods. Identifying the reason for these spikes in blood levels of HIV may increase understanding of disease progression.

Author: Fiscus, Susan A., Heggem-Snow, Aline, Troiani, Luigi, Wallmark, Ewa, Folds, James D., Sheff, Brian, Van der Horst, Charles M.
Development and progression

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen

Article Abstract:

Drug treatment for HIV infection may reduce the amount of virus in semen. Researchers measured HIV RNA in blood and semen samples of 11 HIV-infected men before and after they began treatment with reverse transcriptase inhibitors such as zidovudine. In 82% of the men, levels of HIV in semen dropped after treatment. Five of the men were followed for at least a year and their semen HIV levels continued to be below the level measured before treatment. In much of the world, sexual intercourse is the primary means of HIV transmission.

Author: Cohen, Myron S., Eron, Joseph J., Jr., Fiscus, Susan A., Gilliam, Bruce L., Dyer, John R., Marcus, Cheryl, Zhou, Susan, Wathen, Lynne, Freimuth, William W.
Analysis, Drug therapy, Semen

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women

Article Abstract:

The pharmacokinetics of antiretovials (ARVs) in the female genital tract (FGT) are likely to influence vertical and sexual transmission of HIV, the development of viral resistance, and postexposure regimens. The large differences in cervicovaginal fluid (CVF) penetration suggests that further research into ARV phamacokinetics and drug efficacy in the FGT is necessary.

Author: Cohen, Myron S., Cu-Uvin, Susan, Corbett, Amanda H., Fiscus, Susan A., Min, Sherene S., Rezk, Naser, Kashuba, Angela D. M., Petch, Leslie
Influence, Protease inhibitors, Antiretroviral agents, Reverse transcriptase inhibitors

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Measurement, HIV infection, HIV infections, HIV (Viruses), HIV, Physiological aspects, Antiviral agents
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.